Clinical trial
Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of…
NCT00285402 · Ariston Pharmaceuticals, Inc., Industry · Unknown status
Key facts
| NCT number | NCT00285402 |
|---|---|
| Title | Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine |
| Official title | Intranasal AST-726 Treatment for Prophylaxis of Migraine: A Placebo-Controlled Clinical Study |
| Lead sponsor | Ariston Pharmaceuticals, Inc., Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Migraine, Migraine Headache, Migraine Disorders, Migraine With Aura, Migraine Without Aura |
| Intervention type | Drug |
| Interventions | AST-726 Low dose, AST-726 High dose, AST-726 Placebo |
| Enrollment | 198 |
| Start date | May 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Feb 2, 2006 |
| Last update posted | Feb 8, 2008 |
| Countries | Finland, Netherlands, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: